News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Amgen (AMGN) Drug Shows Promise In Ovarian Cancer



5/21/2010 7:53:11 AM

NEW YORK, May 20 (Reuters) - An experimental drug being developed by Amgen Inc (AMGN.O) appeared to keep recurrent ovarian cancer in check longer when combined with chemotherapy than chemotherapy alone, according to a summary of data from a mid-stage study.

Read at Reuters
Read at Bloomberg


comments powered by Disqus
Reuters
Bloomberg
Amgen
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES